Baidu
map

正向夹层再入真腔技术在冠状动脉慢性完全闭塞病变介入治疗中应用中国专家共识

2021-10-27 复旦大学附属中山医院 中国介入心脏病学杂志

冠状动脉慢性完全闭塞(chronic total occlusion,CTO)病变目前被称为经皮冠状动脉介入治疗最后的堡垒。随着技术进步、器械改进和经验积累,CTO病变介入治疗的成功率和手术效率都有了

中文标题:

正向夹层再入真腔技术在冠状动脉慢性完全闭塞病变介入治疗中应用中国专家共识

发布日期:

2021-10-27

简要介绍:

冠状动脉慢性完全闭塞(chronic total occlusion,CTO)病变目前被称为经皮冠状动脉介入治疗最后的堡垒。随着技术进步、器械改进和经验积累,CTO病变介入治疗的成功率和手术效率都有了明显提高。

相关资料下载:
[AttachmentFileName(sort=1, fileName=正向夹层再入真腔技术在冠状动脉慢性完全闭塞病变介入治疗中应用中国专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=fccdb1c002265320, title=正向夹层再入真腔技术在冠状动脉慢性完全闭塞病变介入治疗中应用中国专家共识, enTitle=, guiderFrom=中国介入心脏病学杂志, authorId=0, author=, summary=冠状动脉慢性完全闭塞(chronic total occlusion,CTO)病变目前被称为经皮冠状动脉介入治疗最后的堡垒。随着技术进步、器械改进和经验积累,CTO病变介入治疗的成功率和手术效率都有了, cover=https://img.medsci.cn/20211117/1637154222754_5579292.jpg, journalId=0, articlesId=null, associationId=2131, associationName=复旦大学附属中山医院, associationIntro=复旦大学附属中山医院, copyright=0, guiderPublishedTime=Wed Oct 27 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">冠状动脉慢性完全闭塞(chronic total occlusion,CTO)病变目前被称为经皮冠状动脉介入治疗最后的堡垒。随着技术进步、器械改进和经验积累,CTO病变介入治疗的成功率和手术效率都有了明显提高。</span></p>, tagList=[TagDto(tagId=3969, tagName=冠脉介入), TagDto(tagId=117982, tagName=冠状动脉慢性完全闭塞病变介入治疗)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=30545, guiderKeyword=冠状动脉慢性完全闭塞病变, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2197, appHits=102, showAppHits=0, pcHits=791, showPcHits=2095, likes=0, shares=21, comments=7, approvalStatus=1, publishedTime=Wed Nov 17 22:10:34 CST 2021, publishedTimeString=2021-10-27, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Wed Nov 17 22:06:29 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Fri Jan 05 00:09:20 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=正向夹层再入真腔技术在冠状动脉慢性完全闭塞病变介入治疗中应用中国专家共识.pdf)])
正向夹层再入真腔技术在冠状动脉慢性完全闭塞病变介入治疗中应用中国专家共识.pdf
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1187311, encodeId=2d8b118e3117a, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9dc96478592, createdName=ms2000001716855301, createdTime=Sat Jan 22 22:03:18 CST 2022, time=2022-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075120, encodeId=ecdd10e5120dd, content=好,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/a9d8887d828e4e5aa6913b151c198a77/5dda65f497734f979445f0322b42e2d0.jpg, createdBy=3b505575469, createdName=黑莓530, createdTime=Mon Nov 29 17:00:36 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074197, encodeId=979310e4197f7, content=不错 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:09:13 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073742, encodeId=ae1010e3742fa, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6035556648, createdName=ms7000000522684854, createdTime=Thu Nov 25 08:40:03 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073741, encodeId=68d510e37413b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6035556648, createdName=ms7000000522684854, createdTime=Thu Nov 25 08:39:50 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2022-01-22 ms2000001716855301

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1187311, encodeId=2d8b118e3117a, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9dc96478592, createdName=ms2000001716855301, createdTime=Sat Jan 22 22:03:18 CST 2022, time=2022-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075120, encodeId=ecdd10e5120dd, content=好,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/a9d8887d828e4e5aa6913b151c198a77/5dda65f497734f979445f0322b42e2d0.jpg, createdBy=3b505575469, createdName=黑莓530, createdTime=Mon Nov 29 17:00:36 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074197, encodeId=979310e4197f7, content=不错 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:09:13 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073742, encodeId=ae1010e3742fa, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6035556648, createdName=ms7000000522684854, createdTime=Thu Nov 25 08:40:03 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073741, encodeId=68d510e37413b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6035556648, createdName=ms7000000522684854, createdTime=Thu Nov 25 08:39:50 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2021-11-29 黑莓530

    好,实用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1187311, encodeId=2d8b118e3117a, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9dc96478592, createdName=ms2000001716855301, createdTime=Sat Jan 22 22:03:18 CST 2022, time=2022-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075120, encodeId=ecdd10e5120dd, content=好,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/a9d8887d828e4e5aa6913b151c198a77/5dda65f497734f979445f0322b42e2d0.jpg, createdBy=3b505575469, createdName=黑莓530, createdTime=Mon Nov 29 17:00:36 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074197, encodeId=979310e4197f7, content=不错 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:09:13 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073742, encodeId=ae1010e3742fa, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6035556648, createdName=ms7000000522684854, createdTime=Thu Nov 25 08:40:03 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073741, encodeId=68d510e37413b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6035556648, createdName=ms7000000522684854, createdTime=Thu Nov 25 08:39:50 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2021-11-26 H8888888

    不错 学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1187311, encodeId=2d8b118e3117a, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9dc96478592, createdName=ms2000001716855301, createdTime=Sat Jan 22 22:03:18 CST 2022, time=2022-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075120, encodeId=ecdd10e5120dd, content=好,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/a9d8887d828e4e5aa6913b151c198a77/5dda65f497734f979445f0322b42e2d0.jpg, createdBy=3b505575469, createdName=黑莓530, createdTime=Mon Nov 29 17:00:36 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074197, encodeId=979310e4197f7, content=不错 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:09:13 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073742, encodeId=ae1010e3742fa, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6035556648, createdName=ms7000000522684854, createdTime=Thu Nov 25 08:40:03 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073741, encodeId=68d510e37413b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6035556648, createdName=ms7000000522684854, createdTime=Thu Nov 25 08:39:50 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2021-11-25 ms7000000522684854

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1187311, encodeId=2d8b118e3117a, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9dc96478592, createdName=ms2000001716855301, createdTime=Sat Jan 22 22:03:18 CST 2022, time=2022-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075120, encodeId=ecdd10e5120dd, content=好,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/a9d8887d828e4e5aa6913b151c198a77/5dda65f497734f979445f0322b42e2d0.jpg, createdBy=3b505575469, createdName=黑莓530, createdTime=Mon Nov 29 17:00:36 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074197, encodeId=979310e4197f7, content=不错 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:09:13 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073742, encodeId=ae1010e3742fa, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6035556648, createdName=ms7000000522684854, createdTime=Thu Nov 25 08:40:03 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073741, encodeId=68d510e37413b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6035556648, createdName=ms7000000522684854, createdTime=Thu Nov 25 08:39:50 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2021-11-25 ms7000000522684854

    学习

    0

拓展阅读

中国冠状动脉慢性完全闭塞病变介入治疗推荐路径

中国冠状动脉慢性闭塞病变介入治疗俱乐部 · 2018-03-30

冠状动脉慢性完全闭塞病变介入治疗的临床证据解读

河北医科大学第二医院心内科 · 2023-02-25

Baidu
map
Baidu
map
Baidu
map